Our VP of Product, David Bazaga, and our VP of Science, Ana Jimenez Pastor, shared some of Quibim’s latest updates since RSNA—highlighting how our growing prostate ecosystem and other solutions continue to evolve, improving patient outcomes and advancing our research and commercial collaborations. Thanks to The Imaging Wire for the insightful discussion! #ECR26 #ProstateCancer
Quibim is at the European Congress of Radiology 2026! 📍 Visit us at Booth AI-34 to meet our team and discover how AI-driven imaging biomarkers are helping to transform radiology and advance precision medicine, providing physicians and researchers around the world with more detailed, data-driven insights. 📅 March 8 | 09:30–11:00, join the session “𝐇𝐨𝐰 𝐀𝐈 𝐢𝐬 𝐫𝐞𝐝𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐩𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫 𝐝𝐞𝐭𝐞𝐜𝐭𝐢𝐨𝐧, 𝐫𝐢𝐬𝐤 𝐬𝐭𝐫𝐚𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐩𝐫𝐨𝐠𝐧𝐨𝐬𝐢𝐬: 𝐟𝐫𝐨𝐦 𝐩𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐭𝐨 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐢𝐦𝐩𝐚𝐜𝐭.” ▪️ Our colleague Gemma Urbanos Garcia will present her research: “𝘐𝘯𝘵𝘦𝘨𝘳𝘢𝘵𝘪𝘯𝘨 𝘈𝘶𝘵𝘰𝘮𝘢𝘵𝘦𝘥 𝘕𝘦𝘶𝘳𝘰𝘷𝘢𝘴𝘤𝘶𝘭𝘢𝘳 𝘉𝘶𝘯𝘥𝘭𝘦 𝘚𝘦𝘨𝘮𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘙𝘢𝘥𝘪𝘰𝘮𝘪𝘤𝘴 𝘉𝘪𝘰𝘮𝘢𝘳𝘬𝘦𝘳𝘴 𝘧𝘰𝘳 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤 𝘢𝘯𝘥 𝘗𝘳𝘰𝘨𝘯𝘰𝘴𝘵𝘪𝘤 𝘔𝘰𝘥𝘦𝘭𝘪𝘯𝘨 𝘪𝘯 𝘗𝘳𝘰𝘴𝘵𝘢𝘵𝘦 𝘊𝘢𝘯𝘤𝘦𝘳.” ▪️ We’re also pleased that Dr. Karen Andreina Bolívar Gil will share her clinical experience and results using QP-Prostate at IAF (Instituto Alexander Fleming): “𝘈𝘳𝘵𝘪𝘧𝘪𝘤𝘪𝘢𝘭 𝘐𝘯𝘵𝘦𝘭𝘭𝘪𝘨𝘦𝘯𝘤𝘦 𝘢𝘴 𝘢 𝘎𝘢𝘵𝘦𝘬𝘦𝘦𝘱𝘦𝘳 𝘪𝘯 𝘗𝘳𝘰𝘴𝘵𝘢𝘵𝘦 𝘊𝘢𝘯𝘤𝘦𝘳 𝘐𝘮𝘢𝘨𝘪𝘯𝘨: 𝘊𝘢𝘯 𝘞𝘦 𝘈𝘷𝘰𝘪𝘥 𝘜𝘯𝘯𝘦𝘤𝘦𝘴𝘴𝘢𝘳𝘺 𝘉𝘪𝘰𝘱𝘴𝘪𝘦𝘴?” #ECR2026 #Radiology #AIinHealthcare #PrecisionMedicine #ProstateCancer #Radiomics
The European Congress of Radiology (ECR) is the perfect opportunity to share some of our latest research. Discover: ▪️ How automated segmentation and advanced radiomic biomarkers are improving diagnosis and prognosis of #ProstateCancer ▪️ How quantitative insights from breast MRI enable more reliable characterization of suspicious findings Book a demo: https://bit.ly/3ZsHpkl #ECR2026 #ECR26 #PrecisionMedicine #DigitalHealth
QP-Prostate goes beyond AI. It brings radiology reading, fusion biopsy, and focal therapy into a single, connected workflow—designed for real collaboration between radiologists and urologists, wherever they are. Disconnected systems slow care. Integrated pathways move it forward. Discover QP-Prostate at the European Congress of Radiology (ECR) booth AI-34, book a demo: https://bit.ly/3ZsHpkl #ECR2026 #Radiology #MedicalImaging #AIinRadiology
En Quibim hemos tenido el privilegio de colaborar en las XVI Jornadas Técnicas de AVISA, donde nuestra compañera María Mancebo González impartió una ponencia sobre un aspecto esencial en el desarrollo de dispositivos médicos basados en IA: avanzar con rigor científico y cumplir todas las exigencias regulatorias, incluso cuando los plazos son exigentes. Solo desde esa disciplina podemos ofrecer a los radiólogos y a los hospitales herramientas precisas, fiables y seguras, como las que desarrollamos con QP‑Prostate. Gracias a AVISA por abrir espacios que impulsan una innovación responsable al servicio de la salud en la Comunitat Valenciana.
Nos enorgullece anunciar que hemos sido galardonados con el Primer Premio a la Responsabilidad Social 2025 (empresas con más de 50 empleados) otorgado por la Generalitat Valenciana. Este reconocimiento pone en valor un modelo empresarial verdaderamente centrado en las personas: el fomento de la innovación tecnológica en salud para favorecer decisiones clínicas más informadas y una experiencia más humana para el paciente, al tiempo que construimos una cultura corporativa basada en el bienestar, la igualdad y un firme compromiso social. Queremos agradecer especialmente a la Conselleria de Economía por este reconocimiento, que refuerza nuestro compromiso de seguir contribuyendo activamente al fortalecimiento y la sostenibilidad de la sanidad pública valenciana.
Ahead of the European Congress of Radiology, we had the opportunity to talk to Prof. Philippe PUECH. In this blog, he shares his perspective on: 🔹 Reducing unnecessary biopsies through smarter multiparametric MRI scans 🔹 Why structured reports are key to PI-RADS consistency 🔹 The real role of AI in prostate MRI and the barriers to its routine adoption 🔹 Why young radiologists should learn to master AI, rather than fear it A practical and forward-looking conversation about how technology and clinical expertise are transforming prostate cancer diagnosis. 👉 Read the full interview on our blog: https://bit.ly/3OAdzrX #ECR2026 #ECR26 #ProstateCancer #AIinHealthcare #MedicalInnovation
As collaborators of Prostate Cancer Research, we understand firsthand how modern imaging techniques, advanced risk stratification, and AI-based diagnostic pathways can redefine prostate cancer screening — making it more accurate, safe, and equitable. The current debate on screening must reflect today's medicine. Decisions that will determine outcomes in the coming years cannot be based on outdated data. They must be based on robust, contemporary evidence and be in line with current clinical practice. Support the call for a fair and modern reassessment of prostate cancer screening in the UK: https://lnkd.in/ecSfYUQA #ProstateCancer #AIinHealthcare #MedicalInnovation
Looking forward to UroNext 2026, taking place 6–7 March in Lisbon at the Hospital CUF Tejo Auditorium, co-organised with David Subira (Coordinator of the Urology Department at CUF - Hospitais e Clínicas) and Bernardino Miñana López, MD PhD (Head of Urology at Clínica Universidad de Navarra). The meeting will bring together experts exploring innovation and AI in uro-oncology. Don’t miss Javier Pizcueta Pastor’s session on AI algorithms for treatment-zone segmentation and post-therapeutic focal assessment — 6 March, 14:30. #UroNext2026 #AIinHealthcare #MedicalInnovation
“𝘛𝘩𝘦 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘵𝘸𝘪𝘯 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘢 𝘴𝘵𝘳𝘢𝘵𝘦𝘨𝘪𝘤 𝘴𝘵𝘦𝘱 𝘵𝘰𝘸𝘢𝘳𝘥 𝘢 𝘮𝘰𝘳𝘦 𝘱𝘳𝘦𝘷𝘦𝘯𝘵𝘪𝘷𝘦 𝘢𝘯𝘥 𝘦𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘮𝘰𝘥𝘦𝘭.” This statement was shared by Ana Jimenez Pastor, VP of Science at Quibim, during her talk at the Longevity World Forum, an event that Quibim has had the pleasure of sponsoring in Madrid. During the event, we showcased how AI-powered solutions transform imaging data into actionable insights that support precision medicine and drive innovation toward healthier aging. #ArtificialIntelligence #MedicalImaging #HealthcareInnovation
